More Galleries
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on Thumbtack.com. More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More
America's favorite businesses From a science camp for girls to a kombucha brewer, communities around the country voted on their favorite small businesses. These 12 came out on top, each scoring a $250,000 grant from Chase and a trip to Google's headquarters. More

Special Offer
13 of 36
BACK NEXT
Outsourced drug research
Outsourced drug research
Amin Zargar, Varnika Roy, Dean Larios Berlin
Team name: Callinix

School: University of Maryland College Park, Clark School of Engineering

Team members: Amin Zargar, Varnika Roy, Dean Larios Berlin

Concept: Callinix aims to help large pharmaceutical firms conduct drug screening and delivery research. Every year, Big Pharma develops thousands of drugs that either remain in pre-clinical stages or are denied FDA approval. These underdeveloped compounds often get sidelined because they are deemed unstable or have side effects.

Callinix positions itself as an outsourced testing partner that will screen the drugs and find more effective ways to deliver them to their targeted tissue. Initially the company plans to target cancer-fighting compounds. It also plans to sell improved drug packaging that it claims will extend the commercial life of existing drugs.

Timeline: Callinix projects that the company will start generating revenue in year three ($325,000) and will more than double sales in each of the following four years. The company expects to become profitable by year four. - Brandi Stewart

NEXT: A new way to halt seizures

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.